Next-level cell lines: An integrated approach to biologic innovation
January 22 @ 11:00 am - 12:00 pm
As artificial intelligence (AI) and digital tools rapidly evolve, they are poised to reshape biopharmaceutical cell line development and subsequent manufacturing, overcoming inefficiencies in expression, scalability, and production.
The webinar will discuss how the Cytiva™ cell culture media platform and Asimov’s CHO Edge system routinely deliver high-titer clones (8–11 g/L) in 14 weeks for monoclonal and multispecific antibodies. We will share a data-driven vision for the future of biologics production and discuss progress toward holistic optimal design of cell lines, genetic systems, and bioprocesses.
